LFCR
Price
$6.81
Change
+$0.07 (+1.04%)
Updated
Oct 23, 04:59 PM (EDT)
Capitalization
252.52M
70 days until earnings call
Intraday Buy/Sell Signals
OGI
Price
$1.73
Change
+$0.04 (+2.37%)
Updated
Oct 23, 04:59 PM (EDT)
Capitalization
227.22M
Intraday Buy/Sell Signals
Interact to see
Advertisement

LFCR vs OGI

Header iconLFCR vs OGI Comparison
Open Charts LFCR vs OGIBanner chart's image
Lifecore Biomedical
Price$6.81
Change+$0.07 (+1.04%)
Volume$1.31K
Capitalization252.52M
Organigram Global
Price$1.73
Change+$0.04 (+2.37%)
Volume$15.21K
Capitalization227.22M
LFCR vs OGI Comparison Chart in %
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. OGI commentary
Oct 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and OGI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 24, 2025
Stock price -- (LFCR: $6.74 vs. OGI: $1.69)
Brand notoriety: LFCR and OGI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 71% vs. OGI: 65%
Market capitalization -- LFCR: $252.52M vs. OGI: $227.22M
LFCR [@Pharmaceuticals: Generic] is valued at $252.52M. OGI’s [@Pharmaceuticals: Generic] market capitalization is $227.22M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.2B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileOGI’s FA Score has 1 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • OGI’s FA Score: 1 green, 4 red.
According to our system of comparison, OGI is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 3 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 3 bullish, 5 bearish.
  • OGI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OGI is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а +0.75% price change this week, while OGI (@Pharmaceuticals: Generic) price change was -13.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.01%. For the same industry, the average monthly price growth was +0.05%, and the average quarterly price growth was +43.59%.

Reported Earning Dates

LFCR is expected to report earnings on Jan 01, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.01% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($253M) has a higher market cap than OGI($227M). OGI has higher P/E ratio than LFCR: OGI (197.70) vs LFCR (51.23). OGI YTD gains are higher at: 8.075 vs. LFCR (-9.287). OGI has higher annual earnings (EBITDA): -959K vs. LFCR (-8.81M). OGI has more cash in the bank: 36.8M vs. LFCR (8.27M). OGI has less debt than LFCR: OGI (9.15M) vs LFCR (131M). OGI has higher revenues than LFCR: OGI (224M) vs LFCR (129M).
LFCROGILFCR / OGI
Capitalization253M227M111%
EBITDA-8.81M-959K919%
Gain YTD-9.2878.075-115%
P/E Ratio51.23197.7026%
Revenue129M224M58%
Total Cash8.27M36.8M22%
Total Debt131M9.15M1,432%
FUNDAMENTALS RATINGS
LFCR vs OGI: Fundamental Ratings
LFCR
OGI
OUTLOOK RATING
1..100
6478
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10089
PRICE GROWTH RATING
1..100
6148
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (86) in the null industry is in the same range as LFCR (99) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

OGI's SMR Rating (89) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

OGI's Price Growth Rating (48) in the null industry is in the same range as LFCR (61) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

OGI's P/E Growth Rating (1) in the null industry is in the same range as LFCR (6) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCROGI
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 24 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HGHAF0.60N/A
N/A
HIGH ARCTIC ENERGY SVCS INC NEW
IBTN28.38N/A
N/A
InsCorp, Inc.
KLKBY5.29N/A
N/A
Kuala Lumpur Kepong Berhad
SGLMF0.44N/A
N/A
Starhill Global Real Estate Investment Trust
GFIOF41.69-1.81
-4.16%
Gold Fields Ltd.

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-0.30%
NBIX - LFCR
36%
Loosely correlated
-0.83%
SHPH - LFCR
31%
Poorly correlated
-7.20%
AMRX - LFCR
31%
Poorly correlated
+1.36%
ALKS - LFCR
29%
Poorly correlated
-1.14%
TKNO - LFCR
28%
Poorly correlated
-1.25%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
+2.96%
SNDL - OGI
67%
Closely correlated
+0.91%
ACB - OGI
65%
Loosely correlated
+1.19%
TLRY - OGI
65%
Loosely correlated
+2.07%
CGC - OGI
62%
Loosely correlated
-3.65%
CRON - OGI
61%
Loosely correlated
+2.90%
More